Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 27

Therapeutics

HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics | Vaccine

HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics

On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…

Read More HHS launched first venture capital partnership to develop transformative technologies to combat future pandemicsContinue

FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics

FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer

On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…

Read More FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancerContinue

Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
COVID-19 | Therapeutics | Vaccine

Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents

On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…

Read More Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescentsContinue

Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19
COVID-19 | Pharmaceutical | Therapeutics

Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19

On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…

Read More Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19Continue

Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases

On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…

Read More Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild casesContinue

NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics

NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut

On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…

Read More NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gutContinue

COVID-19 The Wave
Biotechnology | Cartoons - Original | COVID-19 | Therapeutics | Vaccine

COVID-19 The Wave

Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…

Read More COVID-19 The WaveContinue

Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipeline
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipeline

On May 24, 2021, Moderna and Aldevron announced their expanded collaboration in support of the Moderna COVID-19 Vaccine…

Read More Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipelineContinue

FDA approved first targeted therapy for subset of non-small cell lung cancer
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics

FDA approved first targeted therapy for subset of non-small cell lung cancer

On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…

Read More FDA approved first targeted therapy for subset of non-small cell lung cancerContinue

Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY
Biotechnology | COVID-19 | Life Science History | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY

On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…

Read More Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATYContinue

Scientists discovered rare genetic condition that attacks kids’ immune systems
Biotechnology | Diagnostics | Therapeutics

Scientists discovered rare genetic condition that attacks kids’ immune systems

On May 19, 2021, Megan A. Cooper, MD, PhD, an associate professor of pediatrics at Washington University School…

Read More Scientists discovered rare genetic condition that attacks kids’ immune systemsContinue

Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical study
Biotechnology | COVID-19 | Therapeutics | Vaccine

Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical study

On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…

Read More Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical studyContinue

The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics

The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC

On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…

Read More The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBCContinue

Moderna announced positive initial booster data against SARS-CoV-2 variants
Biotechnology | Infectious Disease | Therapeutics

Moderna announced positive initial booster data against SARS-CoV-2 variants

On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…

Read More Moderna announced positive initial booster data against SARS-CoV-2 variantsContinue

Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeutic
COVID-19 | Infectious Disease | Non-Profit Research | Therapeutics

Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeutic

On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…

Read More Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeuticContinue

CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials

On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…

Read More CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trialsContinue

Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescents

On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…

Read More Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescentsContinue

COVID-19 science and reason
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Life Science History | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO

COVID-19 science and reason

COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…

Read More COVID-19 science and reasonContinue

Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.
Biotechnology | COVID-19 | Disease | Infectious Disease | Oncology | Rare Disease | Therapeutics | Vaccine

Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.

On Apr. 26, 2021, Moderna announced that it had entered into an agreement with Sanofi for fill/finish sterile…

Read More Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.Continue

NIH established new childhood asthma clinical research network
Diagnostics | Disease | Therapeutics

NIH established new childhood asthma clinical research network

On Apr. 23, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had awarded…

Read More NIH established new childhood asthma clinical research networkContinue

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY

On Apr. 19, 2021, Pfizer and BioNTech announced supplying an additional 100 million doses of COMIRNATY, the companies…

Read More Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATYContinue

Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the Northeast
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the Northeast

On Apr. 19, 2021, the Broad Institute of MIT in partnership with the Centers for Disease Control and…

Read More Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the NortheastContinue

Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patients
Biotechnology | Disease | Genomics | Therapeutics

Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patients

On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…

Read More Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patientsContinue

Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19

On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…

Read More Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19Continue

Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodies
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics

Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodies

On Apr. 19, 2021, scientists at the Texas A&M University Global Health Research Complex (GHRC) announced they had…

Read More Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodiesContinue

CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review

On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…

Read More CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling reviewContinue

researchers discovered a gene that causes the most common form of muscular dystrophy in adults
Biotechnology | Disease | Therapeutics

researchers discovered a gene that causes the most common form of muscular dystrophy in adults

On Apr. 15. 2021, a team of researchers led by the University of Minnesota Medical School announced they…

Read More researchers discovered a gene that causes the most common form of muscular dystrophy in adultsContinue

Global shortage of innovative antibiotics fueled emergence and spread of drug-resistance
Therapeutics | WHO

Global shortage of innovative antibiotics fueled emergence and spread of drug-resistance

On Apr. 15, 2021, the World Health Organization (WHO) reported that the world was still failing to develop…

Read More Global shortage of innovative antibiotics fueled emergence and spread of drug-resistanceContinue

NIH funded new influenza research network
Biotechnology | Infectious Disease | Influenza | NIH | Therapeutics | Vaccine

NIH funded new influenza research network

On Apr. 15, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had had established…

Read More NIH funded new influenza research networkContinue

CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to Philippines
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to Philippines

On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…

Read More CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to PhilippinesContinue

Page navigation

Previous PagePrevious 1 … 25 26 27 28 29 … 106 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search